BlackRock Japan’s Pacira BioSciences PCRX Stock Holding History

BlackRock Japan’s Portfolio PCRX Stock Details PCRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-504	Closed	-$17K	–	1356
2016 Q3	$17K	Buy	504 +231	+85%	+$9.05K	﹤0.01%	1144
2016 Q2	$9K	Buy	+273	New	+$13.4K	﹤0.01%	1290
2014 Q2	–	Sell	-1,978	Closed	-$138K	–	1376
2014 Q1	$138K	Buy	+1,978	New	+$135K	﹤0.01%	1009

Other funds holding PCRX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return

GGHC

Gilder Gagnon Howe & Co New York $9.69B AUM 55.7% 1-Year Est. Return

DCM

Daruma Capital Management New York $879M AUM 2.11% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

BlackRock Japan's PCRX Position: Q4 2016 in Review

BlackRock Japan sold out of Pacira BioSciences (PCRX) in Q4 2016, closing a stake of 504 shares — an estimated $17K sold.

BlackRock Japan first reported a position in PCRX in Q1 2014 and held it in 3 quarters. The position peaked at $138K in Q1 2014. 182 funds tracked by Wall St. Rank hold PCRX as of Q4 2016.

BlackRock Japan reported no remaining Pacira BioSciences position as of Q4 2016 after selling out during the quarter.
BlackRock Japan sold 504 Pacira BioSciences shares in Q4 2016, an estimated $17K.
BlackRock Japan first reported a position in Pacira BioSciences in Q1 2014 and held it in 3 quarters.
BlackRock Japan's Pacira BioSciences position peaked at $138K in Q1 2014.
182 funds tracked by Wall St. Rank held Pacira BioSciences as of Q4 2016.

Based on BlackRock Japan's 13F filing for Q4 2016, filed 10 Feb 2017.